Approximately 10% to 20% of medical (nonsurgical) patients develop deep vein thrombosis (DVT) while in the hospital (1), and 70% to 80% of fatal pulmonary emboli occur in medical patients (2-4). As a result, evidence-based guidelines recommend that all hospitalized medical patients should be assessed for their risk of venous thromboembolism (VTE), and those considered to be at risk should receive appropriate thromboprophylaxis with either unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) (1,5). The risk of VTE in medical patients outside the hospital setting is less clear, however. Risk factors that have been identified in hospitalized medical patients, including a history of VTE, cancer, obesity, immobilization, and chronic heart failure (6-8), are also present in some medical outpatients and have been shown to be independent risk factors in this population (9,10). Therefore prevention of VTE in medical outpatients represents an important challenge, particularly for family physicians.
risk of VTE were compared with the level of risk assessed objectively by means of a scorecard developed for use in hospitalized patients (11) .
MATERIALS AND METHODS
The AT-HOME study was an observational cross-sectional study of patients in Germany who had acute medical illnesses and were acutely immobilized at home.
Patients
Patients were eligible for inclusion in the study if they were 18 years of age or older, had a medical illness necessitating acute confinement to bed, and required a home visit from a physician as a result of their medical condition. Physicians were required to enroll consecutive eligible patients. Informed consent was obtained from all patients before enrollment. Patients who had been immobilized in the month before enrollment or who were currently receiving vitamin K antagonists or heparin (LMWH or UFH) were excluded from the study.
Physicians' Risk Assessment
Physicians who contributed to the study were identified from membership databases of the German Society of Angiology, the German Society of Phlebology, and a central health insurance database of physicians in Germany. Many participating physicians were also involved in a simultaneously running national Continuing Medical Education (CME) program designed to raise awareness of VTE. During a visit to the patient's home, physicians recorded patient characteristics, including the evidence-and consensus-based VTE risk factors summarized by Lutz et al. (11) . Physicians then performed a subjective assessment of the patient's risk of VTE. Risk was rated on a scale of 1 to 10, where 1 indicates very low risk and 10 very high risk. No guidelines or risk assessment tools were used by the physicians. The decision on whether to provide thromboprophylaxis was made at the physician's discretion and was based solely on the subjective assessment of risk.
Retrospective Comparison of Risk Assessment
An objective assessment of the risk of VTE was made retrospectively by means of the scorecard developed by Lutz et al. (11) for use in hospitalized medical patients ( Fig. 1 ). This scorecard takes into account of the baseline risk associated with risk factors such as advancing age, obesity, or a previous history of VTE as well as the acute risk related to the patient's current medical condition. Both the baseline and acute risks are stratified according to the level of risk, and the acute risk is superimposed on the baseline risk to produce an overall level of risk.
The objective risk assessment and the provision of thromboprophylaxis in patients at different levels of risk were compared with the physicians' subjective assessments.
RESULTS

Patient Enrollment
A total of 215 primary care physicians, with practices evenly distributed across Germany, recruited patients to the study. Of these, 76% were general practitioners, 22% were internists, and 2% were from other specialties.
Overall, 1247 patients were enrolled in the study, of which 37 were excluded from analysis: 20 were receiving heparin treatment for established DVT, 12 had other major protocol violations, and data from 5 patients could not be verified during follow-up. Thus, the study population comprised 1210 patients.
Patient Characteristics
The baseline characteristics of the 1210 patients analyzed are summarized in Table 1 . More than a third of patients required almost complete bed rest. The most common medical conditions were infections or acute inflammatory diseases, which were present in 73% of patients, followed by heart failure ( Table 2 ). A total of 151 patients (13%) had experienced an ischemic stroke and 7% were paralyzed because of stroke. It should be noted, however, that stroke was not the reason for acute confinement to bed in these patients, who were included in the study because of an additional medical condition requiring confinement to bed.
Predisposing risk factors for VTE were present in almost 90% of patients ( Table 3 ). The most common risk factor was a previous history of VTE, which was present in approximately 57% of patients, followed by major varicosis (55% of patients), dehydration (32%), and a family history of VTE (19%).
Physicians' Risk Assessments and Use of Thromboprophylaxis
Of the 1210 patients, 198 (16%) had risk scores of 0-4, 319 (26%) had scores of 5 or 6, and 693 (57%) had scores of 7 or above. Overall, 966 patients (80%) received thromboprophylaxis, of which 957 (99%) received LMWH. The prescription of thromboprophylaxis correlated with the physicians' assessment of the risk of VTE: the proportion of patients receiving thromboprophylaxis ranged from 0% to 47% in patients with a risk rating of 0-4, to 100% in those with the highest risk rating ( Fig. 2A ).
Retrospective Objective Risk Assessment
Retrospective assessment of the risk of VTE according to the Lutz et al. scorecard (11) revealed that 894 of patients (74%) were considered to be at high risk of VTE, 186 (15%) at intermediate risk, and 130 (11%) at low risk ( Fig. 2B ). Of the patients considered to be at high risk, 87% received thromboprophylaxis, compared with 61% of those at intermediate risk and 55% of those at low risk (Fig. 2B ). In this assessment, patients who had experienced a stroke were automatically placed in the high risk group, irrespective of other medical conditions or risk factors for VTE.
DISCUSSION
The "basic risk" profile (predisposing risk factors) of medical outpatients in the AT-HOME (13) With paralysis 90 (7) Acute decompensated COPD 165 (14) Heart failure (NYHA III or IV) 280 (23) Infectious diarrhea 111 (9) Acute deterioration of chronically infected intestines 38 (3) Other/nonspecified acute inflammatory disease 162 (13) Infusion of venotoxic solutions via CVC or port catheter 18 (2) Other acute noninflammatory disease 53 (4) Other reasons for home visit 124 (10) Patients with data on reasons of home visit 1206 (99.7)
Patients without data on reasons of home visit 4 (0.3)
Several diagnoses were possible in an individual patient. Characteristics listed in data collection forms were based on those in the risk-assessment scorecard of Lutz et al (11) . COPD = chronic obstructive pulmonary disease; CVC = central venous catheter; NYHA = New York Heart Association. study was comparable with that of hospitalized acutely ill medical patients, such as those enrolled in the Prophylaxis in Medical Patients with Enoxaparin (MEDENOX) study (6, 12) . Risk factors that were identified as independent predictors of VTE in patients in the MEDENOX study, such as history of VTE and malignancy, were also frequently identified in patients in the AT-HOME study. For example, of patients in the AT-HOME study, 8% had an active malignancy and 17% were obese, while 14% of patients in the MEDE-NOX study had active or previous malignancies and 21% were obese. However, the proportions of patients who had a history of VTE or current major varicosis were much higher in the AT-HOME study compared with the MEDENOX study. In the AT-HOME study, 46% of patients had a history of DVT and 11% had a history of pulmonary embolism (PE), whereas in the MEDENOX study, only 9% of patients had a history of VTE (DVT or PE). Major varicosis was present in 55% of patients in the AT-HOME study compared with 25% of patients in the MEDENOX study. This high prevalence of a history of VTE or major varicosis in patients in the AT-HOME study is further illustrated by comparison with the Sirius (9) and Evaluation de l'Incidence des Événements Thromboemboliques Veineux et des Modalités Ambulatoires de Prévention du Risque Thrombo-Embolique en Médicine Générale (ETAPE) (13) studies. Both the Sirius and ETAPE studies were conducted in medical outpatients in France, and only 21% and 14% of patients, respectively, had a history of DVT. The relatively high incidence of prior DVT in the AT-HOME study population might be explained by the fact that a previous DVT could have been mistaken for a superficial thrombophlebitis during the patients' questioning, but it is most likely explained by the different methodologies and objectives of the studies. The Sirius study was a case control study (494 patients with DVT vs 494 patients without DVT) that aimed to determine risk factors for DVT in medical outpatients, whereas ETAPE was a prospective epidemiological study designed to determine the incidence of VTE and risk factors for VTE in acutely ill medical outpatients. Furthermore, neither the Sirius nor ETAPE studies were designed to assess the awareness of physicians for the risk of VTE, the main aim of the AT-HOME study (9, 13) .
The results of the AT-HOME study suggest that participating physicians were aware of the risk of VTE in immobilized medical outpatients and prescribed thromboprophylaxis appropriately. The physicians' subjective assessment of the risk of VTE was comparable with the objective assessment performed retrospectively using the Lutz et al. scorecard (11) , which was developed for use in hospitalized medical patients.
Overall, 80% of the patients in our study received a form of thromboprophylaxis, in most cases LMWH, and only 11% were assessed to be at low risk according to the Lutz et al. scorecard (11) . In comparison, only 35% of patients in the ETAPE study received thromboprophylaxis and 57% were assessed to be at low risk for VTE (13) . The majority of patients in the AT-HOME study (74%) were judged to be at high risk of VTE by using the Lutz et al. scorecard (11) , of which 87% received thromboprophylaxis. However, this finding may not be fully representative of normal physician practices for providing thromboprophylaxis to medical outpatients in Germany. Two factors may have helped physicians to correctly assess the risk of VTE in enrolled patients and therefore led to improved provision of thromboprophylaxis. First, many physicians were participating in a simultaneous-ly running national CME program designed to raise awareness of VTE. Second, the process of recording VTE risk factors in the case report form of the AT-HOME study was clearly structured and very systematic regarding the known DVT risk factors. Regardless of the fact that no score was used, this structured way of documenting DVT risk factors may have raised the subjective awareness of the physicians.
These two factors are the most likely explanation for the fact that a substantially higher percentage of patients received thromboprophylaxis compared with the French College of Internal Medicine of Paris (CIMOP) and Donnees Epidemiologiques chez les Patients A Risque Thromboembolique (DEPART) studies, in which only 44% of medical outpatients received thromboprophylaxis (14) . Similarly, in a recent community-based assessment of the risk of VTE in immobilized medical outpatients, the proportion of patients receiving thromboprophylaxis ranged from 56% in those judged to be at highest risk of VTE to 27% in the lowest risk group (13) . Although physicians in the AT-HOME study appeared to be aware of the risk of VTE and the need for thromboprophylaxis in at-risk medical outpatients, this may also have led to the provision of thromboprophylaxis to some patients for whom it may not have been necessary. For instance, 55% of patients who were judged to be at low risk of VTE according to the Lutz et al. scorecard (11) received thromboprophylaxis. However, this only represents 6% of the overall patient population. If specific risk factors such as major varicosis or obesity were to be moved from risk score 1 to 2, which may be justifiable given that they were found to significantly increase the risk of DVT in medical outpatients in the SIRIUS study, this would reduce the proportion of patients who would have been classed as low risk.
The AT-HOME study is subject to some limitations. Although physicians were required to enroll consecutive eligible patients, this could not be verified. As a result, we cannot exclude the possibility that the AT-HOME study population does not completely reflect the medical outpatient population in Germany in terms of VTE risk. Furthermore, in some cases, patients may have had more than one documented illness-related risk factor. For example, patients who had previously experienced a stroke could have had a minor acute exposing risk, which would normally have led to them being rated as low risk in the physician's subjective assessment. However, because stroke overrides all other exposing risk fac-tors in the scorecard of Lutz et al. (11) , such patients would automatically have been included in the high risk group in the retrospective assessment.
In conclusion, most medical outpatients in the AT-HOME study had a high risk of VTE. Their risk was comparable with the risk of hospitalized acutely ill medical patients. Physicians participating in the study provided the majority of atrisk medical outpatients with thromboprophylaxis, which was probably a result of, at least in part, concurrently running physician education programs designed to raise the awareness of VTE and of the standardized and structured documentation of acute and chronic risk factors in the case report form.
NOTE
